| Serial profiling of circulating tumor DNA identifies dynamic evolution of clinically actionable genomic alterations in high-risk neuroblastoma KR Bosse, AM Giudice, MV Lane, B McIntyre, PM Schürch, ... Cancer discovery 12 (12), 2800-2819, 2022 | 22 | 2022 |
| Enhanced engraftment of human myelofibrosis stem and progenitor cells in MISTRG mice V Lysenko, N Wildner-Verhey van Wijk, K Zimmermann, MC Weller, ... Blood advances 4 (11), 2477-2488, 2020 | 16 | 2020 |
| Production and characterization of peptide antibodies to the C-terminal of frameshifted calreticulin associated with myeloproliferative diseases FP Mughal, AC Bergmann, HUB Huynh, SH Jørgensen, I Mansha, ... International Journal of Molecular Sciences 23 (12), 6803, 2022 | 9 | 2022 |
| Blocking the CD47-SIRPα interaction reverses the disease phenotype in a polycythemia vera mouse model V Lysenko, PM Schürch, S Tuzlak, NWV van Wijk, LV Kovtonyuk, ... Leukemia 37 (6), 1277-1286, 2023 | 3 | 2023 |
| Calreticulin mutations affect its chaperone function and perturb the glycoproteome PM Schürch, L Malinovska, M Hleihil, M Losa, MC Hofstetter, ... Cell Reports 41 (8), 2022 | 3 | 2022 |
| Proteogenetic drug response profiling elucidates targetable vulnerabilities of myelofibrosis MHE Wildschut, J Mena, C Dördelmann, M van Oostrum, BD Hale, ... Nature Communications 14 (1), 6414, 2023 | 2 | 2023 |
| The ASC inflammasome adapter controls the severity of inflammation-related AA amyloidosis M Losa, M Emmenegger, P De Rossi, PM Schuerch, T Serdiuk, N Pengo, ... | 1 | 2021 |
| GPC2 directed CAR T cells are efficacious against fusion-positive and fusion-negative rhabdomyosarcomas R Shraim, PM Schuerch, AM Giudice, KL Conkrite, AK Weiner, ... Cancer Research 84 (6_Supplement), 1090-1090, 2024 | | 2024 |
| Neuroblastoma extracellular vesicles present GPC2 and activate GPC2 CAR T cells in an antigen-dependent manner AM Giudice, S Matlaga, G Pascual-Pasto, PM Schuerch, G Rouin, ... Cancer Research 84 (6_Supplement), 5118-5118, 2024 | | 2024 |
| The ASC inflammasome adapter controls the extent of peripheral protein aggregate deposition in inflammation-associated amyloidosis M Losa, M Emmenegger, P De Rossi, PM Schürch, T Serdiuk, N Pengo, ... bioRxiv, 2021.05. 01.442282, 2021 | | 2021 |
| Exploiting macrophage checkpoint interactions to control Polycythemia Vera V Lysenko, P Schuerch, WVN van Wijk, L Kovtonyuk, MG Manz, ... ONCOLOGY RESEARCH AND TREATMENT 43 (SUPPL 4), 77-77, 2020 | | 2020 |
| PS1439 ENHANCED SUPPORT OF MYELOFIBROSIS STEM CELLS IN NEXT GENERATION HUMANIZED MICE V Lysenko, N Wildner, K Zimmermann, MC Weller, P Schürch, C Fritz, ... HemaSphere 3 (S1), 663-664, 2019 | | 2019 |
